Cottonwood Capital Advisors LLC raised its holdings in The Cigna Group (NYSE:CI – Free Report) by 80.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,629 shares of the health services provider’s stock after acquiring an additional 726 shares during the quarter. Cottonwood Capital Advisors LLC’s holdings in The Cigna Group were worth $450,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in CI. The Manufacturers Life Insurance Company raised its holdings in The Cigna Group by 145.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 683,361 shares of the health services provider’s stock worth $225,899,000 after buying an additional 404,791 shares during the period. International Assets Investment Management LLC increased its position in shares of The Cigna Group by 49,287.7% in the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after acquiring an additional 399,230 shares in the last quarter. FMR LLC raised its holdings in shares of The Cigna Group by 2.0% during the third quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock valued at $4,929,978,000 after acquiring an additional 279,880 shares during the period. Raymond James & Associates lifted its position in shares of The Cigna Group by 42.8% in the 3rd quarter. Raymond James & Associates now owns 860,050 shares of the health services provider’s stock valued at $297,956,000 after acquiring an additional 257,711 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in The Cigna Group by 68.4% in the 4th quarter. Assenagon Asset Management S.A. now owns 497,875 shares of the health services provider’s stock worth $137,483,000 after purchasing an additional 202,161 shares during the period. Institutional investors own 86.99% of the company’s stock.
Analyst Ratings Changes
CI has been the subject of a number of research analyst reports. Truist Financial reduced their target price on The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays increased their price objective on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Stephens reissued an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a research report on Friday, November 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $395.93.
The Cigna Group Stock Performance
CI opened at $294.18 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The company has a market cap of $81.83 billion, a PE ratio of 27.75, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The stock has a 50-day moving average of $297.72 and a 200-day moving average of $325.82. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.
The Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. During the same quarter in the prior year, the business earned $6.77 earnings per share. The company’s revenue was up 29.8% on a year-over-year basis. As a group, equities research analysts forecast that The Cigna Group will post 28.5 earnings per share for the current fiscal year.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than The Cigna Group
- Election Stocks: How Elections Affect the Stock Market
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to buy stock: A step-by-step guide for beginners
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Which Wall Street Analysts are the Most Accurate?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.